@article{ff13cc027b9b47e68d9bf58ce4d6b45e,
title = "ACNP task force report on SSRIs and suicidal behavior in youth",
abstract = "This Task Force report by the American College of Neuropsychopharmacology evaluates the safety and efficacy of selective serotonin reuptake inhibitor (SSRIs) antidepressants for depressed youth under 18 years. The report was undertaken after regulatory agencies in the United States and United Kingdom raised concerns in 2003 about the possibility that treatment of depression in children and adolescents with SSRIs may increase the risk of suicidal thinking or suicide attempts.",
keywords = "Adolescents, Adults, Antidepressants, Children, Suicide, Suicide attempts",
author = "Mann, {J. John} and Graham Emslie and Baldessarini, {Ross J.} and William Beardslee and Fawcett, {Jan A.} and Goodwin, {Frederick K.} and Leon, {Andrew C.} and Meltzer, {Herbert Y.} and Ryan, {Neal D.} and David Shaffer and Wagner, {Karen D.}",
note = "Funding Information: The members of the Task Force are: Graham Emslie, MD, J John Mann, MD, Ross J Baldessarini, MD, William Beardslee, MD, Jan Fawcett, MD, Andrew C Leon, PhD, Herbert Meltzer, MD, Fredrick Goodwin, MD, David Shaffer, MD, Karen Wagner, MD, PhD, and Neal Ryan, MD. A list of Task Force members, their academic affiliation, and disclosure of potential conflicts of interest for each member is available at (http://www.acnp.org/ exec_summary.pdf). The ACNP is a nonprofit, professional society with revenues from a variety of sources, including membership dues, publication sales, and registration fees. The ACNP also receives a substantial share of its revenue from pharmaceutical industry grants. The ACNP Task Force on SSRIs and Suicide received no fees and the cost of the report was supported solely by the ACNP.",
year = "2006",
month = mar,
doi = "10.1038/sj.npp.1300958",
language = "English (US)",
volume = "31",
pages = "473--492",
journal = "Neuropsychopharmacology",
issn = "0893-133X",
publisher = "Nature Publishing Group",
number = "3",
}